ANI (ANIP) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

ANI Pharmaceuticals (ANIP) reported $247.06 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 29.6%. EPS of $2.33 for the same period compares to $1.63 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $232.98 million, representing a surprise of +6.04%. The company delivered an EPS surprise of +17.32%, with the consensus EPS estimate being $1.99.While investors closely watch year-over-year changes in headline numbers -- revenue and ea ...